

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T-helper 1 type immune response (GO:0042088) | 8.37274225 |
| 2 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 7.06340300 |
| 3 | antibacterial humoral response (GO:0019731) | 7.00752432 |
| 4 | immunoglobulin mediated immune response (GO:0016064) | 6.86732388 |
| 5 | antimicrobial humoral response (GO:0019730) | 6.59400482 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.41502877 |
| 7 | innate immune response in mucosa (GO:0002227) | 6.33975672 |
| 8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.18718069 |
| 9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.03117706 |
| 10 | complement activation, classical pathway (GO:0006958) | 5.80769337 |
| 11 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 5.56721081 |
| 12 | B cell mediated immunity (GO:0019724) | 5.55063803 |
| 13 | mucosal immune response (GO:0002385) | 5.42154421 |
| 14 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.32681895 |
| 15 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 5.30420195 |
| 16 | positive regulation of macrophage cytokine production (GO:0060907) | 5.26188167 |
| 17 | interferon-gamma-mediated signaling pathway (GO:0060333) | 5.11690021 |
| 18 | tongue development (GO:0043586) | 5.08703306 |
| 19 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 5.02484130 |
| 20 | organ or tissue specific immune response (GO:0002251) | 4.97525917 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.87065974 |
| 22 | humoral immune response (GO:0006959) | 4.83282552 |
| 23 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.80115132 |
| 24 | detection of bacterium (GO:0016045) | 4.79571898 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.62204506 |
| 26 | cellular response to type I interferon (GO:0071357) | 4.56229256 |
| 27 | type I interferon signaling pathway (GO:0060337) | 4.56229256 |
| 28 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.53766524 |
| 29 | complement activation (GO:0006956) | 4.49846632 |
| 30 | response to type I interferon (GO:0034340) | 4.48627165 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 4.46872377 |
| 32 | myeloid dendritic cell differentiation (GO:0043011) | 4.46406245 |
| 33 | detection of other organism (GO:0098543) | 4.44765648 |
| 34 | positive regulation of humoral immune response (GO:0002922) | 4.43938957 |
| 35 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.40228157 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.34458727 |
| 37 | production of molecular mediator of immune response (GO:0002440) | 4.29894303 |
| 38 | B cell proliferation (GO:0042100) | 4.24792887 |
| 39 | positive regulation of respiratory burst (GO:0060267) | 4.22451668 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.11157397 |
| 41 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 4.01571235 |
| 42 | regulation of macrophage cytokine production (GO:0010935) | 4.01214580 |
| 43 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.96598359 |
| 44 | cellular response to interferon-gamma (GO:0071346) | 3.95753248 |
| 45 | myeloid dendritic cell activation (GO:0001773) | 3.94996556 |
| 46 | negative regulation of B cell apoptotic process (GO:0002903) | 3.94912064 |
| 47 | B cell homeostasis (GO:0001782) | 3.93742136 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 3.93654886 |
| 49 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.91206828 |
| 50 | negative thymic T cell selection (GO:0045060) | 3.88860757 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.85491286 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.85491286 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75905259 |
| 54 | response to interleukin-15 (GO:0070672) | 3.75509536 |
| 55 | regulation of antigen processing and presentation (GO:0002577) | 3.74837613 |
| 56 | T cell migration (GO:0072678) | 3.72990816 |
| 57 | positive regulation of cell killing (GO:0031343) | 3.71965996 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 3.70056237 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.69114312 |
| 60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.64531552 |
| 61 | negative regulation of B cell proliferation (GO:0030889) | 3.61463468 |
| 62 | positive regulation of interferon-gamma production (GO:0032729) | 3.60237103 |
| 63 | regulation of respiratory burst (GO:0060263) | 3.57832577 |
| 64 | negative T cell selection (GO:0043383) | 3.56344315 |
| 65 | T cell costimulation (GO:0031295) | 3.55082088 |
| 66 | glomerular filtration (GO:0003094) | 3.53578924 |
| 67 | regulation of B cell apoptotic process (GO:0002902) | 3.51056501 |
| 68 | lymphocyte costimulation (GO:0031294) | 3.50051699 |
| 69 | regulation of B cell proliferation (GO:0030888) | 3.49832786 |
| 70 | respiratory burst (GO:0045730) | 3.46051781 |
| 71 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.45056609 |
| 72 | positive regulation of B cell mediated immunity (GO:0002714) | 3.45056609 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44136278 |
| 74 | response to interferon-gamma (GO:0034341) | 3.42976414 |
| 75 | chromatin assembly (GO:0031497) | 3.41716740 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.40266723 |
| 77 | regulation of cell killing (GO:0031341) | 3.35637638 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.28982002 |
| 79 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.21412352 |
| 80 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.21412352 |
| 81 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.21412352 |
| 82 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.20253096 |
| 83 | protein activation cascade (GO:0072376) | 3.19293214 |
| 84 | adaptive immune response (GO:0002250) | 3.18926658 |
| 85 | positive regulation by symbiont of host defense response (GO:0052509) | 3.18603727 |
| 86 | modulation by symbiont of host defense response (GO:0052031) | 3.18603727 |
| 87 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.18603727 |
| 88 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.18603727 |
| 89 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.18603727 |
| 90 | modulation by symbiont of host immune response (GO:0052553) | 3.18603727 |
| 91 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.18044911 |
| 92 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.14651543 |
| 93 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.13820374 |
| 94 | positive regulation of B cell proliferation (GO:0030890) | 3.10681987 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 3.08750690 |
| 96 | renal filtration (GO:0097205) | 3.07973390 |
| 97 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.07514367 |
| 98 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.03727258 |
| 99 | positive regulation of cytokine production involved in immune response (GO:0002720) | 3.03449527 |
| 100 | regulation of interferon-gamma production (GO:0032649) | 2.98822320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.45713886 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70195421 |
| 3 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.47619845 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.24274261 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.22755902 |
| 6 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.19380384 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.80541041 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.75560591 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.72448338 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70274551 |
| 11 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.55846021 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.48327433 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.33544856 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29516400 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.21433321 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21324809 |
| 17 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 2.00463574 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 11.5848759 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97897093 |
| 20 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.90466401 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.86220803 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82708239 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80595768 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77105507 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76240010 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76073909 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75719491 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68112244 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68099886 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.64790811 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.61237154 |
| 32 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.60784117 |
| 33 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.58020436 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56666629 |
| 35 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.48930126 |
| 36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46407401 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44852041 |
| 38 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39161351 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38712068 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37304738 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36607265 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36442499 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34817291 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28275051 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28234408 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27333509 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24904844 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24754162 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.23518326 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21517199 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21101438 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.19248292 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18604584 |
| 54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.18073260 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17465818 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16518848 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13391629 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.12475635 |
| 59 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.11781407 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09871079 |
| 61 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07355089 |
| 62 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05627625 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04901902 |
| 64 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04288437 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03194335 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02198612 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02163768 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01768117 |
| 69 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01252413 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.98141392 |
| 71 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97150397 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97108763 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97030257 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96837703 |
| 75 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.96277519 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.96060947 |
| 77 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.94972040 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94805325 |
| 79 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94522021 |
| 80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93382173 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.92633143 |
| 82 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92505216 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92113975 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90740196 |
| 85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90069344 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.90000959 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89721040 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89664908 |
| 89 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89559790 |
| 90 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89216409 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.87924435 |
| 92 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.86761747 |
| 93 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86471374 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83912469 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80654919 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.79904079 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.79315848 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.78267664 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.77007469 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76740085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 6.01748413 |
| 2 | MP0005645_abnormal_hypothalamus_physiol | 4.94270867 |
| 3 | MP0005671_abnormal_response_to | 4.74870729 |
| 4 | MP0005387_immune_system_phenotype | 4.32372427 |
| 5 | MP0001790_abnormal_immune_system | 4.32372427 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.98467484 |
| 7 | MP0001800_abnormal_humoral_immune | 3.66910741 |
| 8 | MP0003303_peritoneal_inflammation | 3.07769297 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.07375857 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.96220289 |
| 11 | MP0003436_decreased_susceptibility_to | 2.75287340 |
| 12 | MP0005025_abnormal_response_to | 2.72166663 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.69528002 |
| 14 | MP0002723_abnormal_immune_serum | 2.66775488 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.66343983 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.63263132 |
| 17 | MP0009785_altered_susceptibility_to | 2.52037312 |
| 18 | MP0003724_increased_susceptibility_to | 2.39480030 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.38914376 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.34730226 |
| 21 | MP0001819_abnormal_immune_cell | 2.34427667 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.28274479 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.11064935 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.08458731 |
| 25 | MP0002398_abnormal_bone_marrow | 2.03926144 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.98188106 |
| 27 | MP0005310_abnormal_salivary_gland | 1.96859782 |
| 28 | MP0000716_abnormal_immune_system | 1.89303873 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.89123324 |
| 30 | MP0002419_abnormal_innate_immunity | 1.84560254 |
| 31 | MP0004510_myositis | 1.67332705 |
| 32 | MP0001727_abnormal_embryo_implantation | 1.64796262 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.58549843 |
| 34 | MP0002006_tumorigenesis | 1.57806964 |
| 35 | MP0002429_abnormal_blood_cell | 1.55633639 |
| 36 | MP0005166_decreased_susceptibility_to | 1.52783654 |
| 37 | MP0004947_skin_inflammation | 1.48281862 |
| 38 | MP0002722_abnormal_immune_system | 1.47671290 |
| 39 | MP0001873_stomach_inflammation | 1.40087640 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.37988621 |
| 41 | MP0003866_abnormal_defecation | 1.34038576 |
| 42 | MP0009046_muscle_twitch | 1.31955590 |
| 43 | MP0003045_fibrosis | 1.31716949 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.29407802 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.28722054 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.21381496 |
| 47 | MP0008469_abnormal_protein_level | 1.15727989 |
| 48 | MP0002405_respiratory_system_inflammati | 1.12292986 |
| 49 | MP0000490_abnormal_crypts_of | 1.08804109 |
| 50 | MP0001663_abnormal_digestive_system | 1.06117674 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.05731526 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.05486726 |
| 53 | MP0005623_abnormal_meninges_morphology | 0.97519511 |
| 54 | MP0000343_altered_response_to | 0.96517213 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 0.93056441 |
| 56 | MP0006082_CNS_inflammation | 0.90610359 |
| 57 | MP0001853_heart_inflammation | 0.86216477 |
| 58 | MP0003075_altered_response_to | 0.83183151 |
| 59 | MP0000249_abnormal_blood_vessel | 0.80623354 |
| 60 | MP0002136_abnormal_kidney_physiology | 0.80282650 |
| 61 | MP0002254_reproductive_system_inflammat | 0.79459849 |
| 62 | MP0000858_altered_metastatic_potential | 0.77945168 |
| 63 | MP0000604_amyloidosis | 0.76733350 |
| 64 | MP0003448_altered_tumor_morphology | 0.75655440 |
| 65 | MP0009643_abnormal_urine_homeostasis | 0.74801653 |
| 66 | MP0005165_increased_susceptibility_to | 0.73934737 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.72876279 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 0.70975090 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 0.69428224 |
| 70 | MP0009763_increased_sensitivity_to | 0.67596813 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 0.64632249 |
| 72 | MP0001348_abnormal_lacrimal_gland | 0.63755423 |
| 73 | MP0001881_abnormal_mammary_gland | 0.61763207 |
| 74 | MP0009764_decreased_sensitivity_to | 0.61009298 |
| 75 | MP0005451_abnormal_body_composition | 0.58863161 |
| 76 | MP0002396_abnormal_hematopoietic_system | 0.58797626 |
| 77 | MP0008874_decreased_physiological_sensi | 0.58476495 |
| 78 | MP0002933_joint_inflammation | 0.57559340 |
| 79 | MP0000477_abnormal_intestine_morphology | 0.56382333 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 0.52843516 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.52631059 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52301264 |
| 83 | MP0003091_abnormal_cell_migration | 0.52118891 |
| 84 | MP0002822_catalepsy | 0.49888505 |
| 85 | MP0005390_skeleton_phenotype | 0.49845589 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.49191722 |
| 87 | MP0002132_abnormal_respiratory_system | 0.49170824 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.48837402 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.47909337 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.47490999 |
| 91 | MP0003329_amyloid_beta_deposits | 0.46415600 |
| 92 | MP0001851_eye_inflammation | 0.46387030 |
| 93 | MP0001542_abnormal_bone_strength | 0.44796406 |
| 94 | MP0000609_abnormal_liver_physiology | 0.43034912 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.41186220 |
| 96 | MP0005023_abnormal_wound_healing | 0.41177175 |
| 97 | MP0003252_abnormal_bile_duct | 0.38247873 |
| 98 | MP0009642_abnormal_blood_homeostasis | 0.38221165 |
| 99 | MP0002168_other_aberrant_phenotype | 0.37956525 |
| 100 | MP0009931_abnormal_skin_appearance | 0.37720317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gastrointestinal stroma tumor (HP:0100723) | 8.40164571 |
| 2 | Recurrent sinusitis (HP:0011108) | 6.77275013 |
| 3 | Recurrent bronchitis (HP:0002837) | 6.14775632 |
| 4 | Dry hair (HP:0011359) | 5.90640852 |
| 5 | Agammaglobulinemia (HP:0004432) | 5.85688921 |
| 6 | Onycholysis (HP:0001806) | 5.53668045 |
| 7 | IgA deficiency (HP:0002720) | 5.45097317 |
| 8 | IgM deficiency (HP:0002850) | 5.38217312 |
| 9 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 5.26407616 |
| 10 | Lymphopenia (HP:0001888) | 4.99955333 |
| 11 | Vasculitis (HP:0002633) | 4.89667021 |
| 12 | Urticaria (HP:0001025) | 4.82622541 |
| 13 | Meningitis (HP:0001287) | 4.72107971 |
| 14 | Eczematoid dermatitis (HP:0000976) | 4.68038760 |
| 15 | Premature loss of primary teeth (HP:0006323) | 4.56552118 |
| 16 | Emphysema (HP:0002097) | 4.54108770 |
| 17 | Cellulitis (HP:0100658) | 4.42384440 |
| 18 | Abnormality of macrophages (HP:0004311) | 4.29031291 |
| 19 | Recurrent pneumonia (HP:0006532) | 4.26429376 |
| 20 | Conical tooth (HP:0000698) | 4.21874375 |
| 21 | Abnormality of incisor morphology (HP:0011063) | 4.10032785 |
| 22 | Ridged nail (HP:0001807) | 4.06803424 |
| 23 | Chronic diarrhea (HP:0002028) | 3.93886710 |
| 24 | Skin rash (HP:0000988) | 3.86510567 |
| 25 | Prostate neoplasm (HP:0100787) | 3.85514918 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 3.83006564 |
| 27 | Bronchitis (HP:0012387) | 3.78645578 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.77499295 |
| 29 | Recurrent lower respiratory tract infections (HP:0002783) | 3.63613905 |
| 30 | Restrictive lung disease (HP:0002091) | 3.53002739 |
| 31 | Squamous cell carcinoma (HP:0002860) | 3.49257040 |
| 32 | IgG deficiency (HP:0004315) | 3.44206616 |
| 33 | Abnormality of the prostate (HP:0008775) | 3.44006096 |
| 34 | Recurrent abscess formation (HP:0002722) | 3.34946336 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 3.32287194 |
| 36 | Osteomyelitis (HP:0002754) | 3.32277940 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.17796503 |
| 38 | Erythema (HP:0010783) | 3.17029221 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.14375235 |
| 40 | Increased IgM level (HP:0003496) | 3.10417827 |
| 41 | Colitis (HP:0002583) | 3.10343655 |
| 42 | Basal cell carcinoma (HP:0002671) | 3.08088205 |
| 43 | Recurrent otitis media (HP:0000403) | 3.02772234 |
| 44 | Increased IgE level (HP:0003212) | 2.81284540 |
| 45 | Abnormal gallbladder physiology (HP:0012438) | 2.78456993 |
| 46 | Cholecystitis (HP:0001082) | 2.78456993 |
| 47 | Obstructive lung disease (HP:0006536) | 2.76252154 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.76252154 |
| 49 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.68251051 |
| 50 | Recurrent viral infections (HP:0004429) | 2.63947401 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.62582481 |
| 52 | Sparse scalp hair (HP:0002209) | 2.61325495 |
| 53 | Verrucae (HP:0200043) | 2.58131522 |
| 54 | Papilloma (HP:0012740) | 2.58131522 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.57141378 |
| 56 | Abnormality of B cell number (HP:0010975) | 2.54016854 |
| 57 | Petechiae (HP:0000967) | 2.53753374 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.53642357 |
| 59 | B lymphocytopenia (HP:0010976) | 2.52589745 |
| 60 | Sepsis (HP:0100806) | 2.51490795 |
| 61 | Recurrent skin infections (HP:0001581) | 2.49045120 |
| 62 | Lymphoma (HP:0002665) | 2.47154951 |
| 63 | Hypotrichosis (HP:0001006) | 2.44442370 |
| 64 | Leukopenia (HP:0001882) | 2.41340986 |
| 65 | Chronic otitis media (HP:0000389) | 2.39695762 |
| 66 | Arthralgia (HP:0002829) | 2.39604119 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.38606648 |
| 68 | Xerostomia (HP:0000217) | 2.35565254 |
| 69 | Abnormality of T cells (HP:0002843) | 2.34741597 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.26361594 |
| 71 | Spontaneous hematomas (HP:0007420) | 2.26175315 |
| 72 | Hypergammaglobulinemia (HP:0010702) | 2.25809358 |
| 73 | Abnormality of male internal genitalia (HP:0000022) | 2.24477038 |
| 74 | Abnormality of the pleura (HP:0002103) | 2.23963951 |
| 75 | Blepharitis (HP:0000498) | 2.20517366 |
| 76 | Panhypogammaglobulinemia (HP:0003139) | 2.14177714 |
| 77 | Hypertensive crisis (HP:0100735) | 2.13813878 |
| 78 | Purpura (HP:0000979) | 2.06100264 |
| 79 | Skin ulcer (HP:0200042) | 2.05679077 |
| 80 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03981520 |
| 81 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03981520 |
| 82 | Acanthosis nigricans (HP:0000956) | 2.03784935 |
| 83 | Plantar hyperkeratosis (HP:0007556) | 2.03547502 |
| 84 | Cutaneous photosensitivity (HP:0000992) | 2.02051150 |
| 85 | Hepatitis (HP:0012115) | 2.00674040 |
| 86 | Bronchiectasis (HP:0002110) | 2.00222766 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.99644214 |
| 88 | Optic neuritis (HP:0100653) | 1.99644214 |
| 89 | Abnormality of primary teeth (HP:0006481) | 1.99568679 |
| 90 | Teleangiectasia of the skin (HP:0100585) | 1.98514863 |
| 91 | Encephalitis (HP:0002383) | 1.97990971 |
| 92 | Hypermelanotic macule (HP:0001034) | 1.94160646 |
| 93 | Gingivitis (HP:0000230) | 1.92014597 |
| 94 | Neutropenia (HP:0001875) | 1.90467054 |
| 95 | Orchitis (HP:0100796) | 1.86616362 |
| 96 | Gastrointestinal infarctions (HP:0005244) | 1.84319843 |
| 97 | Chest pain (HP:0100749) | 1.80588128 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 1.77653800 |
| 99 | Elevated hepatic transaminases (HP:0002910) | 1.76457043 |
| 100 | Myositis (HP:0100614) | 1.74002590 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK1 | 6.52986772 |
| 2 | TLK1 | 4.68572125 |
| 3 | ZAK | 4.12275212 |
| 4 | DAPK3 | 3.79686584 |
| 5 | SMG1 | 3.34504540 |
| 6 | RIPK4 | 3.20084263 |
| 7 | MAP4K1 | 3.14077774 |
| 8 | ERN1 | 3.03036390 |
| 9 | IRAK4 | 2.81081876 |
| 10 | BCKDK | 2.72074176 |
| 11 | RPS6KA5 | 2.70492057 |
| 12 | BLK | 2.21877813 |
| 13 | MAP3K14 | 2.07480637 |
| 14 | ARAF | 1.99596444 |
| 15 | AURKA | 1.93796104 |
| 16 | TBK1 | 1.83907462 |
| 17 | MAP3K13 | 1.78985168 |
| 18 | VRK2 | 1.75339588 |
| 19 | TAF1 | 1.72011662 |
| 20 | SYK | 1.63236265 |
| 21 | IKBKE | 1.61412796 |
| 22 | PRPF4B | 1.60363803 |
| 23 | FGFR4 | 1.56195266 |
| 24 | NEK9 | 1.42792975 |
| 25 | LYN | 1.24069844 |
| 26 | BTK | 1.19536363 |
| 27 | CSF1R | 1.17987411 |
| 28 | EPHA3 | 1.17246334 |
| 29 | MAP3K9 | 1.16590388 |
| 30 | STK4 | 1.15769613 |
| 31 | JAK3 | 1.15692920 |
| 32 | TYK2 | 1.12257251 |
| 33 | KIT | 1.11304082 |
| 34 | JAK1 | 1.09172051 |
| 35 | IKBKB | 1.07500119 |
| 36 | CSK | 0.91729465 |
| 37 | EPHB1 | 0.89627507 |
| 38 | TNK2 | 0.89477891 |
| 39 | SIK3 | 0.88724221 |
| 40 | TESK2 | 0.88407564 |
| 41 | SIK2 | 0.82815142 |
| 42 | BRAF | 0.78208790 |
| 43 | PRKCQ | 0.76891862 |
| 44 | MATK | 0.76332442 |
| 45 | JAK2 | 0.76164056 |
| 46 | MAP3K10 | 0.74892096 |
| 47 | MST1R | 0.74658934 |
| 48 | HIPK2 | 0.72281988 |
| 49 | PIM1 | 0.70832312 |
| 50 | DDR2 | 0.64511075 |
| 51 | BMPR2 | 0.63180071 |
| 52 | MAP3K1 | 0.63029236 |
| 53 | MAP3K8 | 0.61840723 |
| 54 | KDR | 0.61209592 |
| 55 | PIM2 | 0.59172416 |
| 56 | KSR2 | 0.58225460 |
| 57 | CDC42BPA | 0.57321746 |
| 58 | AURKB | 0.54740401 |
| 59 | PKN1 | 0.54709802 |
| 60 | FGFR3 | 0.54233536 |
| 61 | MAPKAPK5 | 0.51545498 |
| 62 | MAPK7 | 0.51291592 |
| 63 | PRKCD | 0.49652579 |
| 64 | SIK1 | 0.49374053 |
| 65 | PDK1 | 0.46625771 |
| 66 | STK10 | 0.43457365 |
| 67 | MAPKAPK3 | 0.43161581 |
| 68 | STK24 | 0.41518188 |
| 69 | CHUK | 0.41473495 |
| 70 | LCK | 0.41455239 |
| 71 | ALK | 0.40368825 |
| 72 | NME2 | 0.39619870 |
| 73 | AKT2 | 0.37273660 |
| 74 | MAPK11 | 0.36814248 |
| 75 | EEF2K | 0.36773209 |
| 76 | GRK5 | 0.36733957 |
| 77 | TESK1 | 0.36176909 |
| 78 | CDK9 | 0.34864602 |
| 79 | MAPKAPK2 | 0.34098578 |
| 80 | FGR | 0.32118131 |
| 81 | ICK | 0.30203481 |
| 82 | NEK1 | 0.29733574 |
| 83 | YES1 | 0.29396652 |
| 84 | MELK | 0.29109478 |
| 85 | HCK | 0.28231856 |
| 86 | CDK19 | 0.27508328 |
| 87 | INSR | 0.26964317 |
| 88 | PIK3CA | 0.26680392 |
| 89 | MARK3 | 0.26366455 |
| 90 | PDPK1 | 0.25045785 |
| 91 | CCNB1 | 0.24397118 |
| 92 | MAPK12 | 0.22524398 |
| 93 | DAPK1 | 0.21640200 |
| 94 | MOS | 0.21467363 |
| 95 | PTK6 | 0.20852319 |
| 96 | FYN | 0.18858919 |
| 97 | ABL1 | 0.18623334 |
| 98 | CHEK2 | 0.17963803 |
| 99 | EIF2AK3 | 0.16644732 |
| 100 | RAF1 | 0.15550028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 7.92722671 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 4.85057197 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.23332652 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.11070759 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.08415789 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.85758335 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.46025960 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.08000483 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.05899157 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83856232 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.62802595 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31955245 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22609389 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19809080 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.18780691 |
| 16 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.99035140 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59408650 |
| 18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.54997342 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26259498 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17508821 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13877872 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.04935070 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04581574 |
| 24 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97615682 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96424209 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93330711 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92771770 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 0.92051174 |
| 29 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91514404 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86860338 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 0.85797706 |
| 32 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65067094 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64632026 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.62631825 |
| 35 | Measles_Homo sapiens_hsa05162 | 0.59277740 |
| 36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55003735 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53644791 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.53181904 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51565902 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 0.45463267 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42123839 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39902381 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38085380 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37516043 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37506382 |
| 46 | Malaria_Homo sapiens_hsa05144 | 0.36406067 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32245918 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 0.32093492 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31772006 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31297904 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30820699 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30473715 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.30273514 |
| 54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29241396 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.28476350 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24605286 |
| 57 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24290669 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.24072018 |
| 59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.23883622 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.23327630 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23194437 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22454596 |
| 63 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21064852 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19555555 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.16798389 |
| 66 | Proteasome_Homo sapiens_hsa03050 | 0.16228253 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.16071950 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.14886434 |
| 69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.13721388 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13587774 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10769851 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.10326038 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.09162738 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.08715528 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.08500625 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.08123486 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.07285384 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.06312923 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.05700836 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.05655822 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.04338830 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.03622075 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.00090265 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.0603936 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.0597493 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | -0.0588772 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0568421 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | -0.0494741 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0482736 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | -0.0459358 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0443797 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | -0.0424255 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | -0.0342094 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0234429 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | -0.0136654 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | -0.0134634 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | -0.0105489 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0045222 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0028179 |
| 100 | Base excision repair_Homo sapiens_hsa03410 | -0.0004919 |

